# TELADOC HEALTH, INC. (TDOC) FY2026 Q3 Balance Sheet

- Company: TELADOC HEALTH, INC. (TDOC)
- Period: As of 2026-09-30
- Filing: Q3 FY2026 10-Q, filed 2026-10-29, accession number 0001477449-26-000052
- Page: https://plicit.ai/financials/tdoc/fy2026-q3-balance-sheet
- Chart image: https://plicit.ai/charts/tdoc-fy2026-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-09-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,775,075,000 US dollars
- **Current assets**: 1,226,010,000 US dollars
- **Non-current assets**: 1,549,065,000 US dollars
- **Liabilities**: 1,480,352,000 US dollars
- **Current liabilities**: 1,415,504,000 US dollars
- **Non-current liabilities**: 64,848,000 US dollars
- **Equity**: 1,294,723,000 US dollars
- **Cash and cash equivalents**: 849,909,000 US dollars
- **Accounts receivable, net of allowance for doubtful accounts of $3,345 and $4,033 at September 30, 2026 and December 31, 2025, respectively**: 230,949,000 US dollars
- **Prepaid expenses and other current assets**: 114,405,000 US dollars
- **Inventories**: 30,747,000 US dollars
- **Intangible assets, net**: 1,117,143,000 US dollars
- **Goodwill**: 283,190,000 US dollars
- **Other assets**: 102,477,000 US dollars
- **Property and equipment, net**: 24,406,000 US dollars
- **Operating lease—right-of-use assets**: 21,849,000 US dollars
- **Convertible senior notes, net—current**: 997,593,000 US dollars
- **Accrued expenses and other current liabilities**: 232,413,000 US dollars
- **Accrued compensation**: 77,147,000 US dollars
- **Deferred revenue, current**: 62,012,000 US dollars
- **Accounts payable**: 46,339,000 US dollars
- **Operating lease liabilities, net of current portion**: 28,125,000 US dollars
- **Deferred taxes, net**: 26,993,000 US dollars
- **Deferred revenue, net of current portion**: 9,122,000 US dollars
- **Other liabilities**: 608,000 US dollars
- **Convertible senior notes, net—non-current**: 0 US dollars
- **Additional paid-in capital**: 17,888,783,000 US dollars
- **Common stock, $0.001 par value; 300,000,000 shares authorized; 182,254,430 shares and 178,315,400 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively**: 182,000 US dollars
- **Accumulated deficit**: negative 16,559,901,000 US dollars
- **Accumulated other comprehensive loss**: negative 34,341,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
